Clinical Trials in Cagliari, CA
10 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 2
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
Anemia
Bristol-Myers Squibb189 enrolled36 locationsNCT05664737
Recruiting
Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Lupus Nephritis
Novartis Pharmaceuticals462 enrolled188 locationsNCT05126277
Recruiting
Not Applicable
Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED
Dry Eye Disease (DED)Dry Eye Syndromes
FB Vision S.p.A74 enrolled2 locationsNCT07412860
Recruiting
Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
Cardiac ArrestStatus Epilepticus
University of Milano Bicocca80 enrolled10 locationsNCT05756621
Recruiting
Not Applicable
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
Coronary DiseaseCoronary Artery DiseaseIschemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus1,420 enrolled34 locationsNCT05027984
Recruiting
Not Applicable
Feasibility Study of Virtual Sail 3D in Cognitive Functions
Mild Cognitive Impairment
University of Cagliari40 enrolled1 locationNCT06579378
Recruiting
Non-ablative Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Prospective Study on Efficacy, Safety, and Quality of Life and Sexuality Impact
Genitourinary Syndrome of Menopause
University of Cagliari50 enrolled1 locationNCT06503003
Recruiting
LOWER: Lomitapide Observational Worldwide Evaluation Registry
Homozygous Familial Hypercholesterolemia
Amryt Pharma300 enrolled75 locationsNCT02135705
Recruiting
BRING-UP Prevention
Peripheral Arterial DiseaseCerebrovascular DisordersIschemic Heart Disease
Heart Care Foundation6,000 enrolled196 locationsNCT06275113